EXHIBIT HALL & KEYNOTE PRESENTATION SCHEDULE:
TUESDAY, MAY 16
5:45 – 7:00 pm Exhibit Hall Open
4:00 – 5:45 pm Plenary Keynote Presentation
4:05 – 4:20 pm Innovative Practices Awards
5:45 – 7:00 pm Welcome Reception in the Exhibit Hall with Poster Viewing
WEDNESDAY, MAY 17
9:30 am – 6:00 pm Exhibit Hall Open
8:00 – 9:30 am Plenary Keynote Presentation
9:30 – 10:15 am Coffee & Networking in the Exhibit Hall with Poster Viewing
9:40 – 10:00 am Solutions Theater Presentation by Ardigen
1:50 – 2:35 pm Refreshments & Networking in the Exhibit Hall with Poster Viewing
2:00 – 2:20pm Solutions Theater Presentation by Thrive Bioscience
2:30 pm Raffle Drawing: Apple AirPods Pro
4:40 – 6:00 pm Best of Show Awards Reception in the Exhibit Hall with Poster Viewing
4:45 – 5:05 pm Solutions Theater Presentation by Ontoforce
THURSDAY, MAY 18
9:30 am – 2:35 pm Exhibit Hall Open
8:00 – 9:30 am Plenary Keynote Presentation
9:30 – 10:15 am Coffee Break in the Exhibit Hall with Poster Viewing
10:00 am Raffle Drawing: Apple Watch
1:50 – 2:35 pm Refreshment Break in the Exhibit Hall with
Poster Viewing
2:20 pm Raffle Drawing: Bose Wireless Headphones
**Exhibit Hours Subject to Change**
In-Person Only
Available for Free Until April 28
Featuring Keynote Presentations By:
TUESDAY, MAY 16 | 4:00 – 5:45 pm
Innovative Practices Awards
Allison Proffitt, Editorial Director, Bio-IT World
PLENARY KEYNOTE PRESENTATION:
The Promise of Data, Analytics, and Technology: Fueling Scientific and Medical Breakthroughs
Anastasia Christianson, PhD, Vice President, Global Head of AI, ML, Analytics, and Data, Pfizer Inc.
Edward Cox, Head & General Manager of Digital Health & Medicines (DHM), Pfizer
The 21st century has been referred to as the Century of Biology. With 90% of the world’s 97 zettabytes of data generated in the past 2 years and 30% of today’s data being healthcare related, how are we using data technology, and advanced
analytics (artificial intelligence, machine learning, and deep learning) to advance our understanding of disease and deliver “breakthroughs that change patients' lives”?
WEDNESDAY, MAY 17 | 8:00 – 9:30 am
PLENARY KEYNOTE PRESENTATION:
Federated Futures: How the Largest Federated Learning Effort in Medicine Will Inform Our Next Steps
Spyridon Bakas, PhD, Assistant Professor, Radiology & Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania
Jason Martin, Principal Engineer AI Research Science, Security Solutions Lab, Intel Labs
Is a federated learning model sufficient to handle data from 71 institutions and more than 6,000 patients located on six continents? Researchers from Penn Medicine and Intel Labs say yes. An interdisciplinary team created the largest to-date global federated
learning effort to develop an accurate and generalizable machine learning model for detecting glioblastoma borders. We will share what we learned about creating and maintaining such a federation, how the software infrastructure evolved over the course
of the study, and how this work will empower the future of high-quality, precision clinical care worldwide.
THURSDAY, MAY 18 | 8:00 – 9:30 am
PLENARY KEYNOTE PRESENTATION:
Assessing Innovation: How Pharma Makes Tech Investment Decisions
Panel Moderator:
Aaron Mann, Chief Executive Officer, Clinical Research Data Sharing Alliance
This panel session will assemble senior leaders who evaluate new technology adoption. We will hold an interactive discussion to help provide transparency in the evaluation and decision-making process for assessing and investing in new technologies. Themes
we will cover include: 1) process for evaluating, piloting, and scaling new technologies and technology approaches; 2) how an organization evaluates an emerging technology vendor landscape; 3) when and how a formal buying process becomes required,
and 4) identifying key stakeholders, decision-makers, and gatekeepers.
Panelists:
April Bingham, Executive Director, Global Medical Compliance and Governance Chapter, Roche
Peter Mesenbrink, PhD, Executive Director, Biostatistics, Novartis Pharmaceuticals
Laszlo Vasko, Senior Director, Clinical Innovation R&D IT, Janssen Pharmaceuticals, Inc.